Cite

HARVARD Citation

    Gao, H. et al. (2022). The optimal duration of capecitabine plus temozolomide in patients with well‐differentiated pancreatic NETs with or without maintenance therapy. Journal of neuroendocrinology. p. n/a. [Online]. 
  
Back to record